Recurrent Prostate Carcinoma
Showing 9976 - 10000 of >10,000
Post-Prostatectomy Incontinence, Urinary Stress Incontinence, Urinary Incontinence Trial in Sherbrooke (Adjustable
Recruiting
- Post-Prostatectomy Incontinence
- +3 more
- Adjustable Transobturator Male System
- Artificial Urinary Sphincter
-
Sherbrooke, Quebec, CanadaHôpital Fleurimont- Centre Hospitalier de l'Université de Sherbr
Jul 14, 2022
Metastatic Castrate Resistant Prostate Cancer Trial in Worldwide (Tasquinimod, Placebo)
Terminated
- Metastatic Castrate Resistant Prostate Cancer
- Tasquinimod
- Placebo
-
Gent, Belgium
- +57 more
Nov 21, 2019
Mitral Valve Regurgitation Trial in Vienna (Kephalios Device 1)
Completed
- Mitral Valve Regurgitation
- Kephalios Device 1
-
Vienna, AustriaMedical University of Vienna - Department of Surgery, Division o
Feb 25, 2021
Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic Trial in Meldola (FC) (Boost of radiotherapy + high dose IL-2
Recruiting
- Metastatic Renal Cell Cancer
- Malignant Melanoma, Metastatic
- Boost of radiotherapy + high dose IL-2 treatment
-
Meldola (FC), FC, ItalyUO Oncologia Medica, IRCCS IRST
Feb 25, 2021
Recurrent Herpes Labialis Trial (BOR15001L7, Docosanol Cream 10%)
Unknown status
- Recurrent Herpes Labialis
- BOR15001L7
- Docosanol Cream 10%
- (no location specified)
Sep 4, 2020
Nasopharyngeal Carcinoma, Radiation Therapy Induced Change, Nutrition Disorders Trial in Guangdong (Formula nutrition)
Recruiting
- Nasopharyngeal Carcinoma
- +2 more
- Formula nutrition
-
Guangdong, Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 14, 2021
Esophageal Squamous Cell Carcinoma Trial in Seoul (Durvalumab)
Active, not recruiting
- Esophageal Squamous Cell Carcinoma
-
Seoul, MA, Korea, Republic ofSamsung Medical Center
Dec 15, 2020
Metastatic Oral Squamous Cell Carcinomas With Molecular
Recruiting
- Oral Squamous Cell Carcinoma
- Surgery
-
Hong Kong, Hong KongThe University of Hong Kong
Sep 9, 2020
Foramen Ovale, Patent, Nickel Sensitivity, Dermatitis Contact Irritant Trial in Athens (Percutaneous Patent Foramen Ovale
Recruiting
- Foramen Ovale, Patent
- +3 more
- Percutaneous Patent Foramen Ovale Closure
-
Athens, Attica, GreeceFirst Department of Cardiology, National and Kapodistrian Univer
May 11, 2021
Cryoablation Versus Radiofrequency Ablation in Treatment of
Terminated
- Immune Response to 3 Approaches
- (no location specified)
Apr 15, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
PMS of Trazenta on the Long-term Use as Add-on Therapy
Completed
- Diabetes Mellitus, Type 2
-
Multiple Locations, Japan(unnamed)
Sep 6, 2019
GPC3 Positive Hepatocellular Carcinoma, CAR-T Cell Immunotherapy Trial in Guangzhou (CAR-T cell immunotherapy)
Withdrawn
- GPC3 Positive Hepatocellular Carcinoma
- CAR-T Cell Immunotherapy
- CAR-T cell immunotherapy
-
Guangzhou, Guangdong, ChinaCentral laboratory in Fuda cancer hospital
Jul 14, 2020
Quality of Life Trial in Milan (red wine)
Not yet recruiting
- Quality of Life
- red wine
-
Milan, ItalyUmberto Capitanio
Aug 2, 2022
Esophageal Squamous Cell Carcinoma Trial in Nanjing (Toripalimab, Paclitaxel liposome/Carboplatin, Intensity-modulated
Recruiting
- Esophageal Squamous Cell Carcinoma
- Toripalimab
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Nov 24, 2020
Malignant Glioma, Glioblastoma Multiforme Trial in Japan (Whole Brain Radiation, Temozolomide, ABT-414)
Completed
- Malignant Glioma
- Glioblastoma Multiforme
- Whole Brain Radiation
- +2 more
-
Nagoya-shi, Aichi, Japan
- +21 more
Sep 1, 2020
Pancreatic Metastases From Renal Cell Carcinoma
Unknown status
- Surgical Procedure
- +2 more
-
Badajoz, SpainGerardo Blanco-Fernández
Nov 2, 2020
Hepatocellular Carcinoma Trial in Nanjing (Tislelizumab in combination with cTACE)
Recruiting
- Hepatocellular Carcinoma
- Tislelizumab in combination with cTACE
-
Nanjing, Jiangsu, ChinaCentre of Interventional Radiology and Vascular Surgery, Departm
Nov 26, 2020
Carcinoma, Hepatocellular Trial in Lianyungang (Apatinib, Placebo)
Completed
- Carcinoma, Hepatocellular
- Apatinib
- Placebo
-
Lianyungang, Jiangsu, ChinaJiangsu hengrui medicine CO. LTD
Jan 31, 2021
Squamous Cell Carcinoma Trial in Petah Tiqva (Diffusing Alpha Radiation Emitters Therapy (DaRT))
Completed
- Squamous Cell Carcinoma
- Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Petah Tiqva, IsraelDavidof Cancer Institution at the Rabin Medical Center Israel
Jan 12, 2021
Urethral Stricture After Transurethral Resection of
Recruiting
- Urethral Stricture, Male
- +2 more
- Transurethral resection of the prostate or bladder
-
Granada, SpainHospital Universitario Virgen de las Nieves
Mar 11, 2021
Esophageal Squamous Cell Carcinoma, Positron Emission Tomography Trial in Zhuhai (Dynamic PET)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Positron Emission Tomography
- Dynamic PET
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital, Sun Yat-sen University
Feb 2, 2021